Trial
NCT05448391
A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)
Phase IIWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Aristea Therapeutics, Inc.
Collaborators
—
Condition
Familial Mediterranean Fever
Intervention
RIST4721
Why stopped
Due to safety findings in other ongoing Phase 2 trials.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-13